Bank of America’s MedAvail Holdings, Inc. Common Stock MDVL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-13
Closed -$58 8373
2023
Q4
$58 Buy
+13
New +$46 ﹤0.01% 7478
2023
Q1
Sell
-2
Closed -$32 8439
2022
Q4
$32 Sell
2
-1
-33% -$29 ﹤0.01% 7894
2022
Q3
$0 Hold
3
﹤0.01% 8340
2022
Q2
$0 Sell
3
-35
-92% -$3.07K ﹤0.01% 8563
2022
Q1
$2K Sell
38
-114
-75% -$6.85K ﹤0.01% 8064
2021
Q4
$11K Buy
152
+96
+171% +$10.3K ﹤0.01% 7684
2021
Q3
$8K Buy
56
+19
+51% +$5.76K ﹤0.01% 7640
2021
Q2
$23K Sell
37
-30
-45% -$19.6K ﹤0.01% 7098
2021
Q1
$47K Buy
67
+57
+570% +$41K ﹤0.01% 6656
2020
Q4
$8K Buy
+10
New +$6.99K ﹤0.01% 6770
2020
Q1
Hold
0
7364
2019
Q4
Hold
0
7515
2019
Q1
Hold
0
7491
2018
Q4
Hold
0
7462
2018
Q3
Hold
0
7531
2018
Q2
Hold
0
7392
2016
Q4
Sell
-1
Closed -$1K 7399
2016
Q3
$1K Buy
+1
New +$1.07K ﹤0.01% 6991
2016
Q2
Hold
0
7459
2014
Q4
Sell
-5
Closed -$43K 8044
2014
Q3
$43K Buy
+5
New +$43K ﹤0.01% 6607

Bank of America's MDVL Position: Q1 2024 in Review

Bank of America sold out of MedAvail Holdings, Inc. Common Stock (MDVL) in Q1 2024, closing a stake of 13 shares — an estimated $58 sold.

Bank of America first reported a position in MDVL in Q3 2014 and held it in 12 quarters. The position peaked at $47K in Q1 2021. 1 fund tracked by Wall St. Rank holds MDVL as of Q1 2024.

  • Bank of America reported no remaining MedAvail Holdings, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Bank of America sold 13 MedAvail Holdings, Inc. Common Stock shares in Q1 2024, an estimated $58.
  • Bank of America first reported a position in MedAvail Holdings, Inc. Common Stock in Q3 2014 and held it in 12 quarters.
  • Bank of America's MedAvail Holdings, Inc. Common Stock position peaked at $47K in Q1 2021.
  • 1 fund tracked by Wall St. Rank held MedAvail Holdings, Inc. Common Stock as of Q1 2024.

Based on Bank of America's 13F filing for Q1 2024, filed 15 May 2024.